Beneficial effects of naringenin in liver diseases: Molecular mechanisms

doi:10.3748/wjg.v24.i16.1679

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (23431)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-9) series.

Item

Count

PDF

1636

HTML

17833

Figures (1-9)

230

Sum=19699

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

740

Download

714

Sum=1454

Publishing Process of This Article

Item

Count

Browse

1111

Download

1167

Sum=2278

Apr 28, 2018 (publication date) through Apr 17, 2024

Times Cited of This Article

Times Cited (225)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Apr 28, 2018; 24(16): 1679-1707
Published online Apr 28, 2018. doi: 10.3748/wjg.v24.i16.1679

Full Size Figure Download Figure

Figure 1 Chemical structure of naringenin, naringin, narirutin, and naringenin-glucoside. The flavonoid naringenin exists in two forms: Glycosylated (naringin, narirutin and naringenin-glucoside) and aglycone (naringenina). There are three types of naringenin glycosides depending of sugar moiety bound to the flavonoid: Naringin (rhamnose), narirutin (rutinose) and naringenin-glucoside (glucose); when the sugar moiety is cleaved by specific enzymes, the aglycone (naringenin) is released.

Citation: Hernández-Aquino E, Muriel P. Beneficial effects of naringenin in liver diseases: Molecular mechanisms. World J Gastroenterol 2018; 24(16): 1679-1707
URL: https://www.wjgnet.com/1007-9327/full/v24/i16/1679.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i16.1679